documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
42 rows where document_type = "Other" and posted_year = 1999 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: docket_id, subtype, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1976-S-0001-0001 | FDA | Methods for Conducting Recall Effectiveness Checks - OPEN FDA-1976-S-0001 | Methods for Conducting Recall Effectiveness Checks | Other | Recommendations | 1999-12-30T05:00:00Z | 1999 | 12 | 2018-03-16T18:14:29Z | 0 | 0 | 090000648051b0d1 | |||
| FDA-1995-S-0039-0156 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 1999-12-28T05:00:00Z | 1999 | 12 | 2009-01-02T05:00:00Z | 2016-09-30T14:23:06Z | 0 | 0 | 090000648055c3f6 | ||
| FDA-1980-N-0074-0068 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFD-560 , Warner Lambert, Consumer Healthcare Prod., CTFA, FDC Reports | Other | MM-Memorandum of Meeting | 1999-12-08T05:00:00Z | 1999 | 12 | 2008-05-30T22:52:47Z | 0 | 0 | 09000064805bb4ba | |||
| FDA-1999-P-0059-0001 | FDA | Reg/Guide to Label Medical Devices contain'g Phthalate Plasticizers-CLOSED FDA-1999-P-0059 | FDA/CDRH to Sanford J Lewis | Other | LET-Letter | 1999-12-07T05:00:00Z | 1999 | 12 | 2008-04-25T00:13:57Z | 0 | 0 | 09000064804a66c0 | |||
| FDA-2020-D-1958-0001 | FDA | FDA-2020-D-1958 | Guidance for Industry: Seafood HACCP Transition Guidance | Other | Guidance | 1999-12-01T05:00:00Z | 1999 | 12 | 2020-09-21T04:00:00Z | 2024-11-12T23:24:59Z | 1 | 0 | 0900006484869392 | ||
| FDA-1999-D-3543-0001 | FDA | Seafood HACCP transition guidance FDA-1999-D-3543 | Guidance for Industry: Seafood HACCP Transition Guidance | Other | Guidance | 1999-12-01T05:00:00Z | 1999 | 12 | 2020-09-30T04:00:00Z | 2024-11-12T23:26:15Z | 1 | 0 | 09000064848a586c | ||
| FDA-1999-P-0127-0001 | FDA | ANDA for Sterile Cefuroxime Sodium, USP FDA-1999-P-0127 | FDA/DMB to Quinn Consulting Services | Other | ACK-Acknowledgement Letter | 1999-11-09T05:00:00Z | 1999 | 11 | 2008-04-25T00:18:38Z | 0 | 0 | 09000064804aea0a | |||
| FDA-1978-N-0018-0437 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to The Procter & Gamble Company | Other | Letter(s) | 1999-11-08T05:00:00Z | 1999 | 11 | 2019-07-26T12:27:36Z | 0 | 0 | 090000648055a6a5 | |||
| FDA-1995-S-0039-0155 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 1999-11-02T05:00:00Z | 1999 | 11 | 2009-01-02T05:00:00Z | 2016-09-30T14:23:06Z | 0 | 0 | 090000648055c3f2 | ||
| FDA-1996-P-0246-0022 | FDA | Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 | Interim Response Letter from FDA CFSAN to Brach and Brock Confections, Hershey Foods Corporation | Other | Letter(s) | 1999-11-01T05:00:00Z | 1999 | 11 | 2014-02-20T05:00:00Z | 2014-02-20T14:23:41Z | 0 | 0 | 0900006480503988 | ||
| FDA-1996-P-0309-0022 | FDA | Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 | Interim Response Letter from FDA/CFSAN to Brach and Brock Confections, Hershey Foods Corporation, and Nestle USA, Inc., King and Spalding | Other | Letter(s) | 1999-10-26T04:00:00Z | 1999 | 10 | 2014-02-20T05:00:00Z | 2014-02-20T12:40:54Z | 0 | 0 | 0900006480504ca1 | ||
| FDA-1999-P-0126-0004 | FDA | Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 | FDA/DMB to Pharmacia & Upjohn Inc. | Other | CR-Correction | 1999-10-26T04:00:00Z | 1999 | 10 | 2008-04-25T00:19:51Z | 0 | 0 | 09000064804ae9ee | |||
| FDA-1999-P-0126-0003 | FDA | Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 | FDA/DMB to Pharmacia & Upjohn | Other | ACK-Acknowledgement Letter | 1999-10-26T04:00:00Z | 1999 | 10 | 2008-04-25T00:19:51Z | 0 | 0 | 09000064804ae9ed | |||
| FDA-1995-S-0039-0158 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 1999-10-13T04:00:00Z | 1999 | 10 | 2009-01-02T05:00:00Z | 2016-09-30T14:23:07Z | 0 | 0 | 090000648055c3fa | ||
| FDA-1995-S-0039-0154 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 1999-09-28T04:00:00Z | 1999 | 9 | 2009-01-02T05:00:00Z | 2016-09-30T14:23:06Z | 0 | 0 | 090000648055c3ef | ||
| FDA-1998-P-0084-0003 | FDA | ANDA for omeprazole delayed-release tablets-CLOSED FDA-1998-P-0084 | Citizen Petition Denial from FDA CDER to AndrxPharmaceuticals, Inc. | Other | Denial of Petition | 1999-09-23T04:00:00Z | 1999 | 9 | 2024-07-17T16:04:00Z | 0 | 0 | 0900006480584d87 | |||
| FDA-1998-P-0018-0002 | FDA | Drug products containing oxycodone hydrocloride tablet suitable-CLOSED FDA-1998-P-0018 | Citizen Petition Approval from FDA CDER to King & Spalding | Other | Approval | 1999-09-23T04:00:00Z | 1999 | 9 | 2024-07-12T16:29:21Z | 0 | 0 | 0900006480563c50 | |||
| FDA-1980-N-0074-0067 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | FDA/CDER to Kleinfeld, Kaplan and Becker | Other | PDN-Petition Denial | 1999-09-14T04:00:00Z | 1999 | 9 | 2008-05-30T22:53:22Z | 0 | 0 | 09000064805bb4a5 | |||
| FDA-1999-P-0126-0002 | FDA | Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 | FDA/CDER to Glaxo Wellcome Inc | Other | LET-Letter | 1999-09-14T04:00:00Z | 1999 | 9 | 2008-04-25T00:19:51Z | 0 | 0 | 09000064804ae9eb | |||
| FDA-1999-P-0125-0001 | FDA | Refuse Abbreviated New Drug Applications for Gabapentin Tablets FDA-1999-P-0125 | Acknowledgement Letter from FDA DMB to Palmer & Dodge, LLP | Other | Acknowledgement Letter/Receipt | 1999-08-13T00:00:00Z | 1999 | 8 | 2025-05-23T00:01:41Z | 0 | 0 | 09000064804ae9c2 | |||
| FDA-1978-N-0018-0436 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association | Other | Letter(s) | 1999-08-03T04:00:00Z | 1999 | 8 | 2019-07-25T18:01:31Z | 0 | 0 | 090000648055a696 | |||
| FDA-1999-P-0043-0001 | FDA | Suitability Petition Propoxyphene Napsylate/Acetaminophen 100mg/325mg as ANDA-CLOSED FDA-1999-P-0043 | Acknowledgment Letter from FDA DDM to Mikart Inc. | Other | Acknowledgement Letter/Receipt | 1999-07-09T04:00:00Z | 1999 | 7 | 2017-04-26T18:14:14Z | 0 | 0 | 09000064804a5f3d | |||
| FDA-1999-P-0079-0001 | FDA | Reclassify Constrained Hip Prosthesis Metal/Polymer FDA-1999-P-0079 | FDA/DMB to Orthopedic Surgical Manufacturers Association | Other | ACK-Acknowledgement Letter | 1999-06-14T04:00:00Z | 1999 | 6 | 2008-04-25T00:00:57Z | 0 | 0 | 09000064804a6902 | |||
| FDA-1995-S-0039-0140 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report | 1999-06-11T04:00:00Z | 1999 | 6 | 2008-12-03T05:00:00Z | 2016-09-30T14:23:00Z | 0 | 0 | 090000648055c3ba | ||
| FDA-1978-N-0018-0808 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Supplement from Merck KGaA | Other | Supplement | 1999-05-11T04:00:00Z | 1999 | 5 | 2019-08-09T14:28:06Z | 0 | 0 | 0900006481a795c8 | |||
| FDA-1995-S-0039-0139 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report | 1999-05-10T04:00:00Z | 1999 | 5 | 2008-12-03T05:00:00Z | 2016-09-30T14:23:00Z | 0 | 0 | 090000648055c3af | ||
| FDA-1980-N-0074-0066 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFD-560 to Consumer Healthcare Products Association | Other | LET-Letter | 1999-05-06T04:00:00Z | 1999 | 5 | 2008-05-30T22:52:54Z | 0 | 0 | 09000064805bb498 | |||
| FDA-1999-P-0058-0001 | FDA | Stay of Action Regarding Approval of Cisplatin Injection-CLOSED FDA-1999-P-0058 | Acknowledgement Letter from FDA DMB to Leydig, Voit & Mayer, Ltd | Other | Acknowledgement Letter/Receipt | 1999-05-06T04:00:00Z | 1999 | 5 | 2024-07-22T17:15:02Z | 0 | 0 | 09000064804a66a5 | |||
| FDA-1996-P-0309-0020 | FDA | Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 | Citizen Petition from Brach and Brock Confections, Hershey Foods Corporation, and Nestle USA, Inc., King and Spalding | Other | Citizen Petition | 1999-04-22T04:00:00Z | 1999 | 4 | 1999-04-22T04:00:00Z | 2024-11-12T04:12:58Z | 1 | 0 | 0900006480504c9c | ||
| FDA-1996-P-0309-0021 | FDA | Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 | Acknowledgement Letter to Brach and Brock Confections, Hershey Foods Corporation, and Nestle USA, Inc., King and Spalding | Other | Acknowledgement Letter/Receipt | 1999-04-22T04:00:00Z | 1999 | 4 | 2014-02-20T05:00:00Z | 2014-02-20T12:38:44Z | 0 | 0 | 0900006480504c9e | ||
| FDA-1978-N-0018-0432 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Acknowledgment Letter from FDA DDM to The Cosmetic, Toiletry & Fragrance Association | Other | Acknowledgement Letter/Receipt | 1999-04-15T04:00:00Z | 1999 | 4 | 2019-07-26T12:31:38Z | 0 | 0 | 090000648055a64e | |||
| FDA-1998-N-0007-0014 | FDA | Omega-3 Fatty Acids/Risk in Adults Cardiovascular Disease FDA-1998-N-0007 | FDA/DDM to Emord & Associates | Other | ACK-Acknowledgement Letter | 1999-03-11T05:00:00Z | 1999 | 3 | 2008-05-16T21:28:35Z | 0 | 0 | 0900006480558c5e | |||
| FDA-1991-V-0023-0004 | FDA | Las Vegas laser rental light shows. FDA-1991-V-0023 | Variance Approval Letter from FDA CDRH to Las Vegas Laser Rental | Other | Approval for Variance (VRA) | 1999-03-11T05:00:00Z | 1999 | 3 | 2023-10-13T12:14:51Z | 0 | 0 | 090000648052867f | |||
| FDA-1999-P-0126-0001 | FDA | Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 | FDA/DMB to Glaxo Wellcome Incorporated | Other | ACK-Acknowledgement Letter | 1999-03-04T05:00:00Z | 1999 | 3 | 2008-04-25T00:19:51Z | 0 | 0 | 09000064804ae9e6 | |||
| FDA-1986-V-0024-0002 | FDA | Rainbow Hene Serial #3050 FDA-1986-V-0024 | Arizona Radiation Regulatory Agency - Letter | Other | LET-Letter | 1999-02-10T05:00:00Z | 1999 | 2 | 2013-07-27T21:22:11Z | 0 | 0 | 090000648050dfc6 | |||
| FDA-1995-S-0039-0064 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report | 1999-02-05T05:00:00Z | 1999 | 2 | 2008-10-06T04:00:00Z | 2016-09-30T14:22:30Z | 0 | 0 | 090000648055c3a4 | ||
| FDA-1998-P-0018-0001 | FDA | Drug products containing oxycodone hydrocloride tablet suitable-CLOSED FDA-1998-P-0018 | Acknowledgment Letter from FDA DMB to King & Spalding | Other | Acknowledgement Letter/Receipt | 1999-01-25T05:00:00Z | 1999 | 1 | 2024-07-13T21:26:27Z | 0 | 0 | 0900006480563bf8 | |||
| FDA-1998-N-0042-0001 | FDA | Dietary Supplements of Health Claims FDA-1998-N-0042 | Report of the Commission on Dietary Supplement Labels | Other | Report | 1999-01-22T05:00:00Z | 1999 | 1 | 2024-11-19T15:10:17Z | 0 | 0 | 090000648056e5c6 | |||
| FDA-1980-N-0074-0065 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFA-305 to Colgate-Palmolive Company | Other | ACK-Acknowledgement Letter | 1999-01-08T05:00:00Z | 1999 | 1 | 2008-05-30T22:53:16Z | 0 | 0 | 09000064805bb495 | |||
| FDA-1995-S-0039-0066 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report | 1999-01-04T05:00:00Z | 1999 | 1 | 2008-10-06T04:00:00Z | 2016-09-30T14:22:30Z | 0 | 0 | 0900006480738cd9 | ||
| FDA-2020-D-1959-0001 | FDA | FDA-2020-D-1959 | Small Entity Compliance Guide: Statement of Identity, Nutrition Labeling and Ingredient Labeling of Dietary Supplements | Other | Guidance | 1999-01-03T05:00:00Z | 1999 | 1 | 2020-09-21T04:00:00Z | 2024-11-12T23:24:59Z | 1 | 0 | 0900006484869397 | ||
| FDA-2020-D-1960-0001 | FDA | FDA-2020-D-1960 | Guidance for Industry: Questions and Answers on HACCP Regulation for Fish and Fishery Products | Other | Guidance | 1999-01-01T05:00:00Z | 1999 | 1 | 2020-09-21T04:00:00Z | 2026-01-24T12:02:39Z | 1 | 0 | 0900006484869399 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);